Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Angus

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Cancer Research|November 29, 2017
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital ImagingHailey E Brighton, Steven P Angus, Tao Bo, et al.
Journal of the American Heart Association|October 21, 2017
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor InhibitionTimothy J Stuhlmiller, Jon S Zawistowski, Xin Chen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 1, 2020
A molecular basis for neurofibroma-associated skeletal manifestations in NF1Yun Ma, Andrea M Gross, Eva Dombi, et al.
Targeted Oncology|August 21, 2019
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing LymphomaSteven I Park, Carolina P Lin, Natalie Ren, et al.
Research Square|June 30, 2025
An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networksOlivia Lazaro, Sihong Li, William Carter, et al.
Cancer Discovery|June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology GroupElliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Molecular Cancer Research : MCR|April 20, 2019
GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast CancerSamantha M Bevill, Jose F Olivares-Quintero, Noah Sciaky, et al.
Cancer Research Communications|March 20, 2025
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid LeukemiaAditya S Sheth, Ka-Kui Chan, Sheng Liu, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to LamivudineD J Tenney, S M Levine, R E Rose, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2025
Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumorsSameer Farouk Sait, Kwan Ho Tang, Steven P Angus, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Cancer Research|November 29, 2017
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital ImagingHailey E Brighton, Steven P Angus, Tao Bo, et al.
Journal of the American Heart Association|October 21, 2017
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor InhibitionTimothy J Stuhlmiller, Jon S Zawistowski, Xin Chen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 1, 2020
A molecular basis for neurofibroma-associated skeletal manifestations in NF1Yun Ma, Andrea M Gross, Eva Dombi, et al.
Targeted Oncology|August 21, 2019
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing LymphomaSteven I Park, Carolina P Lin, Natalie Ren, et al.
Research Square|June 30, 2025
An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networksOlivia Lazaro, Sihong Li, William Carter, et al.
Cancer Discovery|June 13, 2024
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology GroupElliot Stieglitz, Alex G Lee, Steven P Angus, et al.
Molecular Cancer Research : MCR|April 20, 2019
GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast CancerSamantha M Bevill, Jose F Olivares-Quintero, Noah Sciaky, et al.
Cancer Research Communications|March 20, 2025
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid LeukemiaAditya S Sheth, Ka-Kui Chan, Sheng Liu, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to LamivudineD J Tenney, S M Levine, R E Rose, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2025
Hydroxychloroquine prevents resistance and potentiates the antitumor effect of SHP2 inhibition in NF1-associated malignant peripheral nerve sheath tumorsSameer Farouk Sait, Kwan Ho Tang, Steven P Angus, et al.
Pageof 10